The World: New York - Novartis picks DDB Worldwide in $350m review

The pharmaceutical manufacturer Novartis AG has added DDB Worldwide to its roster following a review of its $350 million global ad business.

DDB has been selected to work with its Omnicom sibling, the healthcare specialist Cline Davis & Mann.

As part of the review, Novartis has also reappointed the New York outfit Deutsch, which handles below-the-line ads for the Zelnorm and Lamisil brands.

Become a member of Campaign

Get the very latest news and insight from Campaign with unrestricted access to, plus get exclusive discounts to Campaign events.

Become a member

What is Campaign AI?

Our new premium service offering bespoke monitoring reports for your company.

Find out more

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content